DNA

DNA EV to Operating Cash Flow

-5.86×TTM

Retrieved:

DNA FY EV/OCF
DNA FY EV/OCF28.50×-279.45×
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

DNA ev to operating cash flow history

Enterprise value to operating cash flow ratio. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Ginkgo Bioworks Holdings Inc Class EV to Operating Cash Flow — Annual fiscal periods
Period endingEV to Operating Cash Flow
-4.2882×
-1.301×
-8.7159×
-7.7776×
-37.1403×
-91.6516×
-249.6465×

Compare ev to operating cash flow

All DNA financial metrics · DNA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.